In several models of epilepsy, activation of PP2A with sodium selenate has been shown to reduce h-tau, and early treatment imparts anti-epileptogenic effects, while also reducing behavioral deficits associated with the epilepsy (Liu et al., 2016). Here, PTPA is linked to epilepsy.